Expert Perspectives & Insights into CAR T-cell Therapy in Relapsed / Refractory Acute Lymphoblastic Leukemia - Episode 9
Expert Perspectives on Bridging Therapy Strategies Prior to CAR T-cell Therapy
Medical experts examine the importance of bridging therapies preceding CAR T-cell infusion, addressing their frequency of use and preferred therapeutic agents for this purpose.
Video content above is prompted by the following:
- What is the role of bridging therapies prior to CAR T-cells being infused?
- How frequently do you utilize bridging therapy? What agents do you typically use?
- What is the impact of bridging therapies on clinical outcomes post CAR T therapy?
Related Content:
